-
EH/CAH eCQMs - Eligible Hospitals/Critical Access Hospitals
-
Resolution: Answered
-
Moderate
-
None
-
None
-
-
CMS0071v11
-
enoxaparin 90 mg is not recognized as appropriate anticoagulant therapy at discharge (STK 3)
If the patient is discharged home with Lovenox 90 mg (0.9ml SQ injection every 12 hours) and still did not pass the measure. the value set includes .8 ML enoxaparin sodium 100 mg/mg prefilled syringe, .8 ML enoxaparin sodium 150 mg/ml prefilled syringe, 1 ML enoxaparin sodium 100 mg/ml prefilled syringe, 1 ML enoxaparin sodium 150 mg/ml prefilled syringe and enoxaparin sodium 100 mg/ml injectable solution. Should the dosage prescribed in my example be counting in the numerator? why is not passing the measure?